Floré by Sun Genomics, a San Diego, California-based start-up that creates personalized probiotics based on an individual’s gut microbiota profile, is currently collaborating with Royal DSM (Heerlen, Netherlands). researching new ingredients for gut health and wellness. The two companies of his have paired up in MassChallenge Switzerland’s sustainable food solutions challenge. DSM Venturing, the investment arm of Royal DSM, also invested in Flore.
“Floré is a late-stage startup involved in gut health and personal nutrition, using patented whole-genome DNA sequencing and gut composition analysis to personalize to each individual’s unique gut microbiome. We will prescribe the probiotics that have been tested,” said the joint press release. “Floré’s platform can detect over 23,000 organisms, including bacteria, parasites, yeast, viruses, phages and fungi. , which supports startups in this field, will collaborate on research, including DSM’s use of Flore’s algorithms to gain insights into new ingredients. In return, DSM will help Flore source quality ingredients for its products and leverage DSM’s deep knowledge base and extensive business network.”
Pieter Wolters, Managing Director of DSM Venturing, added: Flore has an advantage here, as it takes the guesswork out of the most difficult step for many consumers: choosing the right probiotic. ”
